REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Nacional de Vigilancia de Medicamentos y Alimentos (Colombia)

Main Activities: Public Administration
Full name: Instituto Nacional de Vigilancia de Medicamentos y Alimentos Profile Updated: September 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Instituto Nacional de Vigilancia de Medicamentos y Alimentos is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the Public Administration sector. Instituto Nacional de Vigilancia de Medicamentos y Alimentos was incorporated on February 12, 2015. In its most recent financial highlights, the company reported a net sales revenue drop of 84.13% in Q2C2026. Its total assets grew by 7.11% over the same period.

Headquarters
Carrera 10 # 64-60
Bogota D.C.; Bogota D.C; Postal Code: 110231

Contact Details: Purchase the Instituto Nacional de Vigilancia de Medicamentos y Alimentos report to view the information.

Website: http://www.invima.gov.co

Basic Information
Financial Auditors:
Purchase the Instituto Nacional de Vigilancia de Medicamentos y Alimentos report to view the information.
Incorporation Date:
February 12, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after Instituto Nacional de Vigilancia de Medicamentos y Alimentos report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-84.13%▼
Total Operating Revenue
13.69%▲
Operating Profit
1.75%▲
EBITDA
14.12%▲
Net Profit/Loss for the Period
N/A
Total Assets
7.11%▲
Total Equity
-7.36%▼
Operating Profit Margin
5.8%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.52%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?